Immunohistochemical staining confirmed western blot results, which revealed restored MFN1/MFN2 and reduced DRP1/FIS1 expression in DCM-treated mice (Fig. 2K). The gene discussed is MFN2; the disease is familial dilated cardiomyopathy.